ArticlePloS one2015

Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.

Bingbing Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.